Vaccine Effectiveness During an Outbreak of COVID-19 Alpha Variant (B.1.1.7) in a Men’s Correctional Facility in Rural Virginia

Simple item page
dc.contributor.authorSilverman, Rachel A.en
dc.contributor.authorCeci, Alessandroen
dc.contributor.authorCohen, Alasdairen
dc.contributor.authorHelmick, Meaganen
dc.contributor.authorShort, Ericaen
dc.contributor.authorBordwine, Paigeen
dc.contributor.authorFriedlander, Michael J.en
dc.contributor.authorFinkielstein, Carla V.en
dc.coverage.countryUnited Statesen
dc.coverage.stateVirginiaen
dc.date.accessioned2022-06-14T18:58:11Zen
dc.date.available2022-06-14T18:58:11Zen
dc.date.issued2022-07en
dc.date.updated2022-06-14T17:58:16Zen
dc.description.abstractIn April 2021, a COVID-19 outbreak occurred at a correctional facility in rural Virginia, USA. Eighty-four infections were identified among 854 incarcerated persons by facilitywide testing with reverse transcription quantitative PCR (qRT-PCR). We used whole-genome sequencing to link all infections to 2 employees infected with the B.1.1.7α (UK) variant. The relative risk comparing unvaccinated to fully vaccinated persons (mRNA-1273 [Moderna, https:// www.moderna.com]) was 7.8 (95% CI 4.8–12.7), corresponding to a vaccine effectiveness of 87.1% (95% CI 79.0%–92.1%). Average qRT-PCR cycle threshold values were lower, suggesting higher viral loads, among unvaccinated infected than vaccinated cases for the N, E, and S genes. Vaccination was highly effective at preventing SARS-CoV-2 infection in this high-risk setting. This approach can be applied to similar settings to estimate vaccine effectiveness as variants emerge to guide public health strategies during the ongoing pandemic.en
dc.description.versionSubmitted versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.orcidSilverman, Rachel [0000-0003-3082-9664]en
dc.identifier.orcidCohen, Alasdair [0000-0002-9917-8647]en
dc.identifier.orcidFinkielstein, Carla [0000-0002-8417-4643]en
dc.identifier.urihttp://hdl.handle.net/10919/110778en
dc.language.isoenen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectCOVID-19en
dc.subjectVaccinationen
dc.titleVaccine Effectiveness During an Outbreak of COVID-19 Alpha Variant (B.1.1.7) in a Men’s Correctional Facility in Rural Virginiaen
dc.typeArticleen
dc.type.dcmitypeTexten
dc.type.otherArticleen
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/Scienceen
pubs.organisational-group/Virginia Tech/Science/Biological Sciencesen
pubs.organisational-group/Virginia Tech/Veterinary Medicineen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/Population Health Sciencesen
pubs.organisational-group/Virginia Tech/University Research Institutesen
pubs.organisational-group/Virginia Tech/University Research Institutes/Fralin Life Sciencesen
pubs.organisational-group/Virginia Tech/Faculty of Health Sciencesen
pubs.organisational-group/Virginia Tech/All T&R Facultyen
pubs.organisational-group/Virginia Tech/Science/COS T&R Facultyen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/CVM T&R Facultyen
pubs.organisational-group/Virginia Tech/University Research Institutes/Fralin Life Sciences/Durelle Scotten
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Psychiatry and Behavioral Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Psychiatry and Behavioral Medicine/Secondary Appointment-Psychiatry and Behavioral Medicineen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
22-0091.pdf
Size:
546.82 KB
Format:
Adobe Portable Document Format
Description:
Submitted version
Download

Collections

All Faculty Deposits
Destination Area: Global Systems Science (GSS)
Scholarly Works, Fralin Biomedical Research Institute at VTC
Scholarly Works, Population Health Sciences
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)